Navigation Links
Dr. F. Stockmans, One of the Earliest Proponents of Materialise's Surgicase(R) Orthopaedics, States the Case for its Vital Role in the Treatment of Distal Radius Malunions at ASSH 2010

Dr. F. Stockmans, One of the Earliest Proponents of Materialise's Surgicase(R) Orthopaedics, States... -- BOSTON, October 15, 2010 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Trade Show News Click to view news release full screen  

Dr. F. Stockmans, One of the Earliest Proponents of Materialise's Surgicase(R) Orthopaedics, States the Case for its Vital Role in the Treatment of Distal Radius Malunions at ASSH 2010


BOSTON, October 15, 2010 /PRNewswire/ -- Attendees at this year's annual meeting of the American Society for Surgery of the Hand (ASSH) received pre-conference analysis of the advantages of Materialise's SurgiCase(R) Orthopaedics service for treating distal radius malunions. The speaker was renowned hand surgeon Dr. F. Stockmans. He's also one of the first to integrate SurgiCase(R) into his practice as a solution for patients with exceptional needs.

It's been five years since Dr. Stockmans recognized how valuable SurgiCase(R) is to hand and wrist surgeons faced with challenging surgeries: malunions, non-unions or some instances of congenital deformity. The comprehensive service, which centers on the use of CT/MRI scanned images, consists of three components: virtual surgery planning, the generation of 3D patient models, and the construction of cut and drill guides custom-fit to the patient. It gives the surgeon the capability to try multiple approaches to complicated procedures before entering the operation room. Working together, these components help the surgeon repair complex 3D deformations that would otherwise be impossible to treat using conventional 2D techniques.

Dr. Stockmans has published his successful case histories in the latest issue of Orthopreneur. About SurgiCase(R) increased visibility, he says: "After five years of preparatory studies, I'm thrilled that SurgiCase(R) Orthopaedics is finally being introduced to the surgical community. The possibility of visualizing the pathology in 3D and trying different approaches prior to going into surgery is tremendous. Individualized cut and drill guides have helped me shorten the intervention period, enabling me to treat more cases in the same amount of time. The engineers at Materialise are very professional. I feel much more confident going into the OR."

Materialise launched SurgiCase(R) Orthopaedics in the United States at the ASSH. With the development of its SurgiCase(R) cut and drill guides, Materialise will take a huge step towards putting custom tools into the hands of hand and wrist surgeons.

SOURCE Materialise
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimers Disease
2. Materialise Launches SurgiCase(R) Orthopaedics: A Comprehensive, Custom Solution That Assures Best Practices For The Orthopaedic Surgeon
3. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
4. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
5. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
6. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
7. United States, Canada and Mexico Agree to Mutual Assistance During Public Health Emergencies
8. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
9. Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis
10. A First-Line Therapy for Renal Cell Carcinoma that can Increase Overall Survival when Compared with Sutent Would Earn a Higher Patient Share in the United States Than in Europe
11. American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  Boston Scientific Corporation (NYSE: ... Oppenheimer 26th Annual Healthcare Conference on December 8, in ... Susie Lisa , vice president, Investor Relations, will participate ... beginning at approximately 8:35 a.m. ET. --> ... in a 30-minute question-and-answer session with the host analyst ...
(Date:11/24/2015)...   Renowned UAE ... s advice and insights on supplements and healthy diet ... 50% of Dubai residents are not ...   femMED launches comprehensive solutions for women , ... residents are not consuming enough to keep themselves healthy. A local ...
(Date:11/24/2015)... 2015 Abaxis, Inc. (NasdaqGS: ABAX ), ... for the medical, research, and veterinary markets worldwide, announced ... will present at the 27 th Annual Piper ... 11:30 a.m. ET. The conference will be held at ... York City . Abaxis, Inc. is ...
Breaking Medicine Technology:
(Date:11/24/2015)... UT (PRWEB) , ... November 24, 2015 , ... It ... Magazine. For a business, it is critical that the first impression be positive and ... they are not likely to buy anything or want to return. They will also ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... their knowledge and experiences at a live taping of the next CURE ... the Cure of Gastrointestinal Cancers 2015 Symposium at Georgetown University Hotel & Conference ...
(Date:11/24/2015)... ... ... Aided by seed funding from the Ron Foley Foundation, researchers at Western ... how to detect and treat pancreatic cancer (PC). , WCHN researchers will focus ... (ncRNA), genetic material that is present in the blood of patients with PC. ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... its exceptional customer service: the TrustDale certification. The award recognizes good companies for ... stone honing , tile and grout, and hard surface restoration company earned this ...
(Date:11/24/2015)... ... November 24, 2015 , ... World Patent Marketing ... a household invention that revolutionizes the vending machine industry by providing healthy and ... worth $2 billion," says Scott Cooper, CEO and Creative Director of World Patent ...
Breaking Medicine News(10 mins):